OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes
Yang Liu, Jianying Liu, Jing Zou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Yang Liu, Jianying Liu, Jing Zou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
Hongjie Xia, Jason Yeung, Birte Kalveram, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Hongjie Xia, Jason Yeung, Birte Kalveram, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 5
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 5
Antigenic Cartography Indicates That the Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 after Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
Ekaterina A. Astakhova, Alexei A. Morozov, Maria G. Byazrova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10493-10493
Open Access | Times Cited: 6
Ekaterina A. Astakhova, Alexei A. Morozov, Maria G. Byazrova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10493-10493
Open Access | Times Cited: 6
Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters
Julia R. Port, Claude Kwe Yinda, Jade C. Riopelle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Julia R. Port, Claude Kwe Yinda, Jade C. Riopelle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Antigenic Cartography Indicates That Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 After Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
Ekaterina A. Astakhova, Alexey A. Morozov, Maria G. Byazrova, et al.
(2023)
Open Access | Times Cited: 4
Ekaterina A. Astakhova, Alexey A. Morozov, Maria G. Byazrova, et al.
(2023)
Open Access | Times Cited: 4
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Bioproduction and immunogenic evaluation of SARS-CoV-2 prototype vaccine in silkworm BmN cells
Hao Zheng, Hengfeng Zhao, Haifan Xiong, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 134027-134027
Closed Access | Times Cited: 1
Hao Zheng, Hengfeng Zhao, Haifan Xiong, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 134027-134027
Closed Access | Times Cited: 1
A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide
Feroza Begum, Sreyashi Chandra, Md Hasan Mallik, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150579-150579
Closed Access | Times Cited: 1
Feroza Begum, Sreyashi Chandra, Md Hasan Mallik, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150579-150579
Closed Access | Times Cited: 1
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Enhanced Detection and Molecular Modeling of Adaptive Mutations in SARS-CoV-2 Coding and Non-Coding Regions Using the c/µ Test
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination
Teresa Harthaller, Barbara Falkensammer, David Bante, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Teresa Harthaller, Barbara Falkensammer, David Bante, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines
Sabrina E. Vinzón, María V. López, Eduardo G. Cafferata, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Sabrina E. Vinzón, María V. López, Eduardo G. Cafferata, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
Hongjie Xia, Jason Yeung, Birte Kalveram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Hongjie Xia, Jason Yeung, Birte Kalveram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
